Evidence map›Paper›PMID 35819954›Full record

ArticlePloS one2022

Potential and challenges for an integrated management of tuberculosis, diabetes mellitus, and hypertension: A scoping review protocol.

Vitri Widyaningsih, Ratih Puspita Febrinasari, Victoria Sari, Clarissa Augustania, Bintang Verlita, Chatarina Wahyuni, Bachti Alisjahbana, Ailiana Santosa, Nawi Ng, Ari Probandari

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Vitri WidyaningsihFaculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.ORCID 0000-0003-0116-7120
Ratih Puspita FebrinasariFaculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.ORCID 0000-0001-9767-3284
Victoria SariDisease Control Research Group, Universitas Sebelas Maret, Surakarta, Indonesia.
Clarissa AugustaniaDisease Control Research Group, Universitas Sebelas Maret, Surakarta, Indonesia.
Bintang VerlitaDisease Control Research Group, Universitas Sebelas Maret, Surakarta, Indonesia.
Chatarina WahyuniFaculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Bachti AlisjahbanaFaculty of Medicine, Universitas Padjajaran, Bandung, Indonesia.
Ailiana SantosaSchool of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Nawi NgSchool of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ari ProbandariFaculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia.ORCID 0000-0003-3171-5271
Sebelas Maret University · IDUniversity of Gothenburg · SEAirlangga University · IDPadjadjaran University · ID

Funding

Medical Research Council MR/T038837/1Medical Research Council MR/V030825/1
6 · The paper itself

Abstract

In many low- and middle-income countries (LMICs), the epidemiological transition is characterized by an increased burden of non-communicable diseases (NCDs) and the persistent challenge of infectious diseases. The transmission of tuberculosis, one of the leading infectious diseases, can be halted through active screening of risk groups and early case findings. Studies have reported comorbidities between tuberculosis (TB) and NCDs, which necessitates the development of an integrated disease management model. This scoping review discusses the possibilities and problems of integration in managing TB and NCDs, with a particular emphasis on diabetic mellitus (DM) and hypertension screening and control. We will conduct this review following Arksey and O'Malley's framework for scoping review. We will use key terms related to integrated management, i.e., screening, diagnosis, treatment, and care, of TB, DM, and hypertension in PubMed, Scopus Database, and ScienceDirect for research published from January 2005 to July 2021. This review will also consider grey literature, including unpublished literature and international disease management guidelines on TB, DM, and hypertension from WHO or other health professional organization. We will export the search results to citation manager software (EndNote). We will remove duplicates and apply the inclusion and exclusion criteria to identify the set of papers for the review. After screening the titles and abstract, two authors will independently review the full text of selected studies and extract the data. We will synthesize all selected studies qualitatively and the results will be discussed with the experts. The results will be used as the basis of the development of a guideline for integrated TB, DM, and hypertension management.

Indexed as

Diabetes MellitusHypertensionNoncommunicable DiseasesTuberculosisComorbidityHumansScoping Reviews as Topic

Identifiers

PMID35819954
PMCPMC9275721
OpenAlexW4285078775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.